Home›Companies›Biotech & Pharma›Triton Therapeutics

Triton Therapeutics, Inc.

Updated Oct 27, 2026·Latest SEC filing Oct 23, 2025·Suggest an edit

About Triton Therapeutics

Triton Therapeutics is a private company based in Stamford, Connecticut, incorporated in 2025 in Delaware. It has reported $36,355,769 raised in one offering on Form D since October 2025.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Oct 17, 2025Oct 23, 2025$36,355,769fully sold4$9.0MEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Triton Therapeutics's Form D filed Oct 23, 2025.

AM
Annie Mitsak
Director
TS
PF
Paul Fonteyne
President and director

Sources

  1. SECTriton Therapeutics, Inc. filing history